Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-19

Clinical Trial Update: A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing feasibility of combining a ketogenic diet with metformin for glioblastoma, with metabolic imaging endpoints; currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING